Wechselwirkungen von Busulfan

Busulfan (Myleran, Busulfex) hat in den von uns erfassten FDA-Fachinformationen und Faktenblättern 37 dokumentierte Wechselwirkungen: 3 schwerwiegende, 4 mittelschwere, 30 geringfügige und 0, bei denen eine Fachinformation keine relevante Wechselwirkung berichtet. Jeder Eintrag unten zitiert den Satz, auf dem er beruht. Diese Medikamentenseite ist ein Ausgangspunkt, kein Urteil über Ihre persönliche Situation.

Wechselwirkungen laut Fachinformation

Schwerwiegende Wechselwirkungen (3)

  • Do not administer bismuth subcitrate potassium, metronidazole and tetracycline hydrochloride concomitantly with busulfan unless the benefit outweighs the risk. (Fachinformation zu Bismutsubcitrat, Metronidazol und Tetracyclin, Warnhinweise und Vorsichtsmaßnahmen)

  • CyclophosphamidImmunsuppressivumSchwerwiegend

    Hepatic veno-occlusive disease, which may be life threatening, has been reported in patients receiving busulfan, usually in combination with cyclophosphamide or other chemotherapeutic agents prior to bone marrow transplantation. (Fachinformation zu Busulfan, Warnhinweise)

  • MetronidazolAntibiotikumSchwerwiegend

    Busulfan : Increased busulfan serum concentrations; avoid concomitant use, monitor for plasma concentrations and adjust the busulfan dose accordingly. (Fachinformation zu Metronidazol, Arzneimittelwechselwirkungen)

Mittelschwere Wechselwirkungen (4)

  • DeferasiroxEisenpräparatMittelschwer

    Deferasirox increases exposure of busulfan. (Fachinformation zu Deferasirox, Arzneimittelwechselwirkungen)

  • IfosfamidMittelschwer

    Hemorrhagic cystitis is dose‑dependent and the risk is increased with past or concomitant radiation of the bladder or busulfan treatment. (Fachinformation zu Ifosfamid, Warnhinweise und Vorsichtsmaßnahmen)

  • ItraconazolAzol-AntimykotikumMittelschwer

    The concomitant systemic administration of itraconazole to patients receiving high-dose MYLERAN may result in reduced busulfan clearance (see CLINICAL PHARMACOLOGY). (Fachinformation zu Busulfan, Arzneimittelwechselwirkungen)

  • ThiotepaMittelschwer

    Hepatic Veno-Occlusive Disease Hepatic veno-occlusive disease may occur in patients who have received high-dose TEPADINA in conjunction with busulfan and cyclophosphamide [ see Adverse Reactions (6.1) ]. (Fachinformation zu Thiotepa, Warnhinweise und Vorsichtsmaßnahmen)

Geringfügige Erwähnungen (30)

  • Azelastin und FluticasonAntihistaminikumGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • BeclometasonKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • BetamethasonKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • BudesonidKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • Budesonid und FormoterolKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • CiclesonidKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • ClobetasolKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • DeflazacortKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • DesonidKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • DexamethasonKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • FludrocortisonKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • FlunisolidKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • FluocinonidKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • FluticasonKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • Fluticason und SalmeterolKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • HalobetasolKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • HydrocortisonKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • LevothyroxinSchilddrüsenhormonGeringfügig

    Cytologic abnormalities characterized by giant, hyperchromatic nuclei have been reported in lymph nodes, pancreas, thyroid, adrenal glands, liver, and bone marrow. (Fachinformation zu Busulfan, Warnhinweise)

  • Levothyroxin und LiothyroninSchilddrüsenhormonGeringfügig

    Cytologic abnormalities characterized by giant, hyperchromatic nuclei have been reported in lymph nodes, pancreas, thyroid, adrenal glands, liver, and bone marrow. (Fachinformation zu Busulfan, Warnhinweise)

  • LiothyroninSchilddrüsenhormonGeringfügig

    Cytologic abnormalities characterized by giant, hyperchromatic nuclei have been reported in lymph nodes, pancreas, thyroid, adrenal glands, liver, and bone marrow. (Fachinformation zu Busulfan, Warnhinweise)

  • MercaptopurinAntimetabolitGeringfügig

    During the pregnancy that resulted in the malformed infant, the mother received x-ray therapy early in the first trimester, mercaptopurine until the third month, then busulfan until delivery. (Fachinformation zu Busulfan, Warnhinweise)

  • MethylprednisolonKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • MometasonKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • Olopatadin und MometasonAntihistaminikumGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • PrednisolonKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • PrednisonKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

  • PropylthiouracilThyreostatikumGeringfügig

    Cytologic abnormalities characterized by giant, hyperchromatic nuclei have been reported in lymph nodes, pancreas, thyroid, adrenal glands, liver, and bone marrow. (Fachinformation zu Busulfan, Warnhinweise)

  • TeriparatidSchilddrüsenhormonGeringfügig

    Cytologic abnormalities characterized by giant, hyperchromatic nuclei have been reported in lymph nodes, pancreas, thyroid, adrenal glands, liver, and bone marrow. (Fachinformation zu Busulfan, Warnhinweise)

  • ThiamazolThyreostatikumGeringfügig

    Cytologic abnormalities characterized by giant, hyperchromatic nuclei have been reported in lymph nodes, pancreas, thyroid, adrenal glands, liver, and bone marrow. (Fachinformation zu Busulfan, Warnhinweise)

  • TriamcinolonKortikosteroidGeringfügig

    The administration of corticosteroids has been suggested, but the results have not been impressive or uniformly successful. (Fachinformation zu Busulfan, Warnhinweise)

Prüfen Sie Busulfan gegen alles, was Sie einnehmen. Fügen Sie Ihre gesamte Liste hinzu; alle Paare werden auf einmal geprüft.

Im Wechselwirkungscheck öffnen

Keine medizinische Beratung. Der Schweregrad gibt die Formulierung der Fachinformation wieder, nicht Ihre persönlichen Umstände. Eine als „schwerwiegend“ eingestufte Wechselwirkung kann unter Aufsicht Routine sein, und eine „geringfügige“ kann bei hohen Dosen von Bedeutung sein. Fragen Sie in einer Apotheke nach.